Literature DB >> 15557242

Increased amounts of the influenza virus nucleoprotein do not promote higher levels of viral genome replication.

Anne E Mullin1, Rosa M Dalton1, Maria Joao Amorim1, Debra Elton1, Paul Digard1.   

Abstract

Influenza virus genome replication requires the virus-encoded nucleoprotein (NP), partly because it is necessary to encapsidate the viral genomic RNA (vRNA) and antigenomic cRNA segments into ribonucleoproteins (RNPs). However, there is also evidence that NP actively regulates viral RNA synthesis and there is a long-standing hypothesis that increased concentrations of NP in the cell are responsible for a switch from genome transcription to replication. Here, this hypothesis is tested in a recombinant setting and in the context of virus infection. In a plasmid-based system for reconstituting active viral RNPs in cells, titration of increasing amounts of NP did not promote higher levels of genome replication relative to transcription, but in fact caused the opposite effect. An approximately fourfold reduction in the ratio of genomic and antigenomic RNAs to mRNA was seen across an 80-fold range of NP plasmid concentrations. When cells were transfected with the same amounts of NP plasmid to establish a concentration gradient of NP prior to virus superinfection, no change in the ratio of cRNA to mRNA was seen for segments 5 and 7, or for the ratio of segment 5 vRNA to mRNA. A slight reduction in the ratio of segment 7 vRNA to mRNA was seen. These findings do not support the simple hypothesis that increased intracellular concentrations of NP promote influenza virus genome replication.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15557242     DOI: 10.1099/vir.0.80518-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  28 in total

1.  Identification of BPR3P0128 as an inhibitor of cap-snatching activities of influenza virus.

Authors:  John T-A Hsu; Jiann-Yih Yeh; Ta-Jen Lin; Mei-Ling Li; Ming-Sian Wu; Chung-Fan Hsieh; Yao Chieh Chou; Wen-Fang Tang; Kean Seng Lau; Hui-Chen Hung; Ming-Yu Fang; Shengkai Ko; Hsing-Pang Hsieh; Jim-Tong Horng
Journal:  Antimicrob Agents Chemother       Date:  2011-09-19       Impact factor: 5.191

2.  Modeling the intracellular dynamics of influenza virus replication to understand the control of viral RNA synthesis.

Authors:  Frank S Heldt; Timo Frensing; Udo Reichl
Journal:  J Virol       Date:  2012-05-16       Impact factor: 5.103

3.  Mutations at alternative 5' splice sites of M1 mRNA negatively affect influenza A virus viability and growth rate.

Authors:  Chiayn Chiang; Guang-Wu Chen; Shin-Ru Shih
Journal:  J Virol       Date:  2008-09-03       Impact factor: 5.103

4.  Mutational analysis of cis-acting RNA signals in segment 7 of influenza A virus.

Authors:  Edward C Hutchinson; Martin D Curran; Eliot K Read; Julia R Gog; Paul Digard
Journal:  J Virol       Date:  2008-09-24       Impact factor: 5.103

5.  A Rab11- and microtubule-dependent mechanism for cytoplasmic transport of influenza A virus viral RNA.

Authors:  Maria Joao Amorim; Emily A Bruce; Eliot K C Read; Agnes Foeglein; Robert Mahen; Amanda D Stuart; Paul Digard
Journal:  J Virol       Date:  2011-02-09       Impact factor: 5.103

Review 6.  The influenza virus RNA synthesis machine: advances in its structure and function.

Authors:  Patricia Resa-Infante; Núria Jorba; Rocio Coloma; Juan Ortin
Journal:  RNA Biol       Date:  2011-03-01       Impact factor: 4.652

7.  A small-RNA enhancer of viral polymerase activity.

Authors:  Jasmine T Perez; Ivan Zlatev; Shilpa Aggarwal; Sailakshmi Subramanian; Ravi Sachidanandam; Baek Kim; Muthiah Manoharan; Benjamin R tenOever
Journal:  J Virol       Date:  2012-10-03       Impact factor: 5.103

8.  Human cytomegalovirus inhibitor AL18 also possesses activity against influenza A and B viruses.

Authors:  Giulia Muratore; Beatrice Mercorelli; Laura Goracci; Gabriele Cruciani; Paul Digard; Giorgio Palù; Arianna Loregian
Journal:  Antimicrob Agents Chemother       Date:  2012-08-20       Impact factor: 5.191

9.  Nuclear dynamics of influenza A virus ribonucleoproteins revealed by live-cell imaging studies.

Authors:  Eva M Loucaides; Johann C von Kirchbach; Agnes Foeglein; Jane Sharps; Ervin Fodor; Paul Digard
Journal:  Virology       Date:  2009-09-09       Impact factor: 3.616

10.  Characterisation of influenza A viruses with mutations in segment 5 packaging signals.

Authors:  Edward C Hutchinson; Helen M Wise; Katerine Kudryavtseva; Martin D Curran; Paul Digard
Journal:  Vaccine       Date:  2009-10-23       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.